GC Genome Corporation (KOSDAQ:340450)

South Korea flag South Korea · Delayed Price · Currency is KRW
7,400.00
-500.00 (-6.33%)
At close: Mar 23, 2026
Market Cap175.02B
Revenue (ttm)31.53B +21.8%
Net Income4.04B
EPS185.00
Shares Out23.65M
PE Ratio40.00
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume181,684
Average Volume278,289
Open7,690.00
Previous Close7,900.00
Day's Range7,150.00 - 7,690.00
52-Week Range6,200.00 - 15,180.00
Betan/a
RSI44.23
Earnings DateApr 3, 2026

About GC Genome

GC Genome Corporation operates as a clinical genome analysis company in South Korea. It offers hereditary cancer, tissue and liquid biopsy genetic, blood cancer, and homologous recombination deficiency tests under the Green Plan names; Guardant360, a blood genetic profiling test; Guardant Reveal, a liquid biopsy microscopic residual disease detection and recurrence monitoring test; and genetic rare disease testing services for chromosomal microarray, targeted exome sequencing, whole exome sequencing, and diagnostic genome sequencing. The compan... [Read more]

Industry Medical - Equipment & Services
Sector Healthcare
Founded 2013
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 340450
Full Company Profile

Financial Performance

Financial Statements